Better Health for All

InnovAge's core business, the PACE model, is entirely devoted to enabling seniors to age independently in their homes, improving quality of care, and reducing hospital admissions, which represents an exceptional commitment to health improvement.

The company focuses on managing care for high-cost, dual-eligible seniors and provides language assistance services free of charge, reaching vulnerable populations. InnovAge also made an equity investment in telehealth platform Jetdoc in August 2021 to develop virtual care and remote patient monitoring for PACE participants and caregivers. However, InnovAge faced significant regulatory challenges in 2021 and 2022, including CMS sanctions for deficiencies such as failure to provide all covered services, meet participant needs, ensure accessible services, coordinate 24-hour care, and manage medical situations. While these sanctions were later lifted, they indicate notable safety incidents. The company's risk transparency is moderate, as it communicates progress on audit findings to regulators monthly but does not explicitly detail comprehensive public disclosure of health risks and benefits. InnovAge is starting to build mental health capabilities that can be deployed to the home, but these are not yet fully established. The company aims for a highly motivated workforce and employs most of its home care professionals, but specific initiatives to strengthen the healthcare workforce in underserved areas are not detailed. While InnovAge is required by law to maintain the privacy of health information and uses safeguards, it also uses and discloses health information for treatment, payment, and healthcare operations, and participates in electronic Health Information Exchange, which carries inherent risks. The company focuses on creating awareness of the value of the PACE program but lacks evidence of broader public health education initiatives.

Fair Money & Economic Opportunity

InnovAge serves approximately 7,740 participants, with about 90% of its PACE recipients being dual-eligible for Medicare and Medicaid, indicating a high share of underserved clients.

As a healthcare delivery company, InnovAge does not offer lending or deposit services, nor does it generate customer finance data, offer financial products, or provide debt products to consumers, making several financial-specific KPIs not applicable. In 2019, InnovAge's private equity owner collected a $66.1 million dividend, which was funded through new debt added to InnovAge’s balance sheet. The company also reported negative net income from 2021 to 2025, indicating no pre-tax profit available for reinvestment in community finance or profit-sharing.

Fair Pay & Worker Respect

InnovAge achieved an 85% worker engagement score in a 2025 employee survey, with 100% of employees participating across all locations.

The company was also recertified as a "Great Place to Work" in May 2025, based on high employee satisfaction.

Fair Trade & Ethical Sourcing

InnovAge Holding Corp. is a healthcare delivery company.

and the provided articles, primarily financial reports and a code of ethics, contain limited information directly related to fair trade and ethical sourcing. For forced_child_labour_incidents, the company's 10-K filing () states that "No incidents reported" for forced or child labor. This indicates zero incidents, and without further evidence of proactive measures like strong monitoring systems or risk assessments, it aligns with the tier for zero incidents where a supplier code of conduct is strictly enforced. No specific, concrete data points were found for fair_trade_cert_share, audit_frequency, traceability_coverage, remediation_speed, ethical_clause_coverage, materials_risk_index, or supplier_diversity_spend.

Honest & Fair Business

InnovAge Holding Corp. agreed to a $27 million investor settlement in 2021 for allegedly making misleading statements about growth potential before its initial public offering.

This settlement was explicitly noted as not a regulatory fine. The company also faced regulatory sanctions, including a cessation of reimbursement for new clients by Colorado and the U.S. Centers for Medicare & Medicaid Services (CMS) due to audit findings of failing to provide required PACE services. These sanctions were imposed in September 2021 and lifted in 2023. No specific monetary value for ethics-related regulatory fines was provided. No other data points for transparency, whistleblower policy, financial restatements, audit coverage, ESG controversy, complaint resolution time, board conflicts, anti-corruption policy, or third-party verification were available in the provided articles.

Kind to Animals

InnovAge Holding Corp. (INNV.US) is listed by crueltyfreeinvesting.org as a company with "No Animal Exploitation".

This indicates a global corporate ban on all animal testing across every product category, aligning with the highest tier for animal testing policy. Consequently, this implies zero animals are used in any testing. As a healthcare service provider for humans, other animal-related KPIs such as cruelty-free product certification, alternative testing usage, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audits for animal welfare, cage-free sourcing, R&D investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, and public policy engagement on animal welfare are not applicable to its core business model.

Zero Waste & Sustainable Products

No evidence was found in the provided articles regarding InnovAge Holding Corp.'s performance on any of the 'Zero Waste & Sustainable Products' KPIs.

The articles primarily focus on financial results and company overviews, and do not contain specific data points related to waste diversion rates, product recyclability, packaging sustainability, or waste reduction initiatives.